The 17th International Congress of Neuromuscular Disease will take place July 5-July 9 in Brussels.

Dear Colleagues,

Our plans for this year’s ICNMD are going very well and everything is coming together quite nicely. With less than 3 months from the Congress, we are more than excited to welcome you all to Brussels in July.

If you have not already, we hope that you will decide to join us as this will be the first time in (4) long years that the ICNMD community will be gathering once again in person.

As always, we will continue to monitor the global situation. The health and safety of the ICNMD community will always be top of mind.

Stay safe in the meantime and we’ll see you soon!

The ICNMD International Congress on Neuromuscular Diseases is organized on behalf of the Specialty Group on Neuromuscular Diseases (NMD) of the World Federation of Neurology (WFN). Since 2014, the Congress has taken place in a two-year cycle.

The aim of the ICNMD Congresses is to offer attendees an updated view on neuromuscular disorders and that networking opportunities increase their international experience and collaborations. The scientific and program committee are invited from all continents around the world to enable this wide spectrum.

Here are the titles of the four plenary sessions: 

Wednesday, July 6 | Trial Readiness and Advances in Therapy in Hereditary and Inflammatory Myopathies

Thursday, July 7 | The ALS-FTD Overlap Syndrome

Friday, July 8 | Guillain-Barré Syndrome: State of the Art and Challenges (Endorsed by ICNMD/PNS Society)

Saturday, July 9 | New Developments in Diagnosis and Treatment of Myasthenia Gravis and Congenital Myasthenic Syndrome

Specialty Group on Neuromuscular Diseases
Chair:
James P. Dyck
Mayo Clinic Adult Neurology and Neurosurgery, Rochester, Minnesota.

ICNMD 22 768x256

.

.